BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30124556)

  • 1. Congenital Myasthenic Syndrome: Spectrum of Mutations in an Indian Cohort.
    Selvam P; Arunachal G; Danda S; Chapla A; Sivadasan A; Alexander M; Thomas MM; Thomas NJ
    J Clin Neuromuscul Dis; 2018 Sep; 20(1):14-27. PubMed ID: 30124556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital myasthenic syndrome in Israel: Genetic and clinical characterization.
    Aharoni S; Sadeh M; Shapira Y; Edvardson S; Daana M; Dor-Wollman T; Mimouni-Bloch A; Halevy A; Cohen R; Sagie L; Argov Z; Rabie M; Spiegel R; Chervinsky I; Orenstein N; Engel AG; Nevo Y
    Neuromuscul Disord; 2017 Feb; 27(2):136-140. PubMed ID: 28024842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Landscape of Congenital Myasthenic Syndromes From Turkey: Novel Mutations and Clinical Insights.
    Yiş U; Becker K; Kurul SH; Uyanik G; Bayram E; Haliloğlu G; Polat Aİ; Ayanoğlu M; Okur D; Tosun AF; Serdaroğlu G; Yilmaz S; Topaloğlu H; Anlar B; Cirak S; Engel AG
    J Child Neurol; 2017 Jul; 32(8):759-765. PubMed ID: 28464723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations.
    Guergueltcheva V; Müller JS; Dusl M; Senderek J; Oldfors A; Lindbergh C; Maxwell S; Colomer J; Mallebrera CJ; Nascimento A; Vilchez JJ; Muelas N; Kirschner J; Nafissi S; Kariminejad A; Nilipour Y; Bozorgmehr B; Najmabadi H; Rodolico C; Sieb JP; Schlotter B; Schoser B; Herrmann R; Voit T; Steinlein OK; Najafi A; Urtizberea A; Soler DM; Muntoni F; Hanna MG; Chaouch A; Straub V; Bushby K; Palace J; Beeson D; Abicht A; Lochmüller H
    J Neurol; 2012 May; 259(5):838-50. PubMed ID: 21975507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes.
    Mihaylova V; Müller JS; Vilchez JJ; Salih MA; Kabiraj MM; D'Amico A; Bertini E; Wölfle J; Schreiner F; Kurlemann G; Rasic VM; Siskova D; Colomer J; Herczegfalvi A; Fabriciova K; Weschke B; Scola R; Hoellen F; Schara U; Abicht A; Lochmüller H
    Brain; 2008 Mar; 131(Pt 3):747-59. PubMed ID: 18180250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and genetic characterisation of a large Indian congenital myasthenic syndrome cohort.
    Polavarapu K; Sunitha B; Töpf A; Preethish-Kumar V; Thompson R; Vengalil S; Nashi S; Bardhan M; Sanka SB; Huddar A; Unnikrishnan G; Arunachal G; Girija MS; Porter A; Azuma Y; Lorenzoni PJ; Baskar D; Anjanappa RM; Keertipriya M; Padmanabh H; Harikrishna GV; Laurie S; Matalonga L; Horvath R; Nalini A; Lochmüller H
    Brain; 2024 Jan; 147(1):281-296. PubMed ID: 37721175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital myasthenic syndrome: Ten years clinical experience from a quaternary care south-Indian hospital.
    Wadwekar V; Nair SS; Tandon V; Kuruvilla A; Nair M
    J Clin Neurosci; 2020 Feb; 72():238-243. PubMed ID: 31889643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delineation of molecular characteristics of congenital myasthenic syndromes in Indian families and review of literature.
    Mishra S; Nair KV; Shukla A
    Clin Dysmorphol; 2023 Oct; 32(4):162-167. PubMed ID: 37646703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital myasthenic syndrome due to DOK7 mutation in a cohort of patients with 'unexplained' limb-girdle muscular weakness.
    Lorenzoni PJ; Kay CSK; Arndt RC; Hrysay NMC; Ducci RD; Fustes OHJ; Töpf A; Lochmüller H; Werneck LC; Scola RH
    J Clin Neurosci; 2020 May; 75():195-198. PubMed ID: 32238315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of patients with congenital myasthenic syndrome caused by COLQ mutations.
    Wargon I; Richard P; Kuntzer T; Sternberg D; Nafissi S; Gaudon K; Lebail A; Bauche S; Hantaï D; Fournier E; Eymard B; Stojkovic T
    Neuromuscul Disord; 2012 Apr; 22(4):318-24. PubMed ID: 22088788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent COLQ mutation in congenital myasthenic syndrome.
    Guven A; Demirci M; Anlar B
    Pediatr Neurol; 2012 Apr; 46(4):253-6. PubMed ID: 22490774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular analysis of a novel COLQ missense mutation causing congenital myasthenic syndrome in a Syrian family.
    Matlik HN; Milhem RM; Saadeldin IY; Al-Jaibeji HS; Al-Gazali L; Ali BR
    Pediatr Neurol; 2014 Jul; 51(1):165-9. PubMed ID: 24938146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel COLQ mutation 950delC in synaptic congenital myasthenic syndrome and symptomatic heterozygous relatives.
    Schreiner F; Hoppenz M; Klaeren R; Reimann J; Woelfle J
    Neuromuscul Disord; 2007 Mar; 17(3):262-5. PubMed ID: 17300939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired receptor clustering in congenital myasthenic syndrome with novel RAPSN mutations.
    Müller JS; Baumeister SK; Rasic VM; Krause S; Todorovic S; Kugler K; Müller-Felber W; Abicht A; Lochmüller H
    Neurology; 2006 Oct; 67(7):1159-64. PubMed ID: 16931511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A common CHRNE mutation in Brazilian patients with congenital myasthenic syndrome.
    Estephan EP; Sobreira CFDR; Dos Santos ACJ; Tomaselli PJ; Marques W; Ortega RPM; Costa MCM; da Silva AMS; Mendonça RH; Caldas VM; Zambon AA; Abath Neto O; Marchiori PE; Heise CO; Reed UC; Azuma Y; Töpf A; Lochmüller H; Zanoteli E
    J Neurol; 2018 Mar; 265(3):708-713. PubMed ID: 29383513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of congenital myasthenic syndromes in Spain.
    Natera-de Benito D; Töpf A; Vilchez JJ; González-Quereda L; Domínguez-Carral J; Díaz-Manera J; Ortez C; Bestué M; Gallano P; Dusl M; Abicht A; Müller JS; Senderek J; García-Ribes A; Muelas N; Evangelista T; Azuma Y; McMacken G; Paipa Merchan A; Rodríguez Cruz PM; Camacho A; Jiménez E; Miranda-Herrero MC; Santana-Artiles A; García-Campos O; Dominguez-Rubio R; Olivé M; Colomer J; Beeson D; Lochmüller H; Nascimento A
    Neuromuscul Disord; 2017 Dec; 27(12):1087-1098. PubMed ID: 29054425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global N-linked Glycosylation is Not Significantly Impaired in Myoblasts in Congenital Myasthenic Syndromes Caused by Defective Glutamine-Fructose-6-Phosphate Transaminase 1 (GFPT1).
    Chen Q; Müller JS; Pang PC; Laval SH; Haslam SM; Lochmüller H; Dell A
    Biomolecules; 2015 Oct; 5(4):2758-81. PubMed ID: 26501342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up.
    Durmus H; Shen XM; Serdaroglu-Oflazer P; Kara B; Parman-Gulsen Y; Ozdemir C; Brengman J; Deymeer F; Engel AG
    Neuromuscul Disord; 2018 Apr; 28(4):315-322. PubMed ID: 29395675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital myasthenic syndrome with novel pathogenic variants in the COLQ gene associated with the presence of antibodies to acetylcholine receptors.
    Tay CG; Fong CY; Li L; Ganesan V; Teh CM; Gan CS; Thong MK
    J Clin Neurosci; 2020 Feb; 72():468-471. PubMed ID: 31831253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The First Case of Congenital Myasthenic Syndrome Caused by a Large Homozygous Deletion in the C-Terminal Region of COLQ (Collagen Like Tail Subunit of Asymmetric Acetylcholinesterase) Protein.
    Laforgia N; De Cosmo L; Palumbo O; Ranieri C; Sesta M; Capodiferro D; Pantaleo A; Iapicca P; Lastella P; Capozza M; Schettini F; Bukvic N; Bagnulo R; Resta N
    Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33353066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.